AI Journal

AI Journal is an authoritative open source platform focusing on artificial intelligence and emerging technologies. It gathers insights and case studies from global industry leaders helping businesses and individuals understand how AI is reshaping the modern business landscape.

Articoli di AI Journal

Renesas Advances Its India and China Strategy with Strengthened Leadership

Malini Narayanamoorthi Expands India Leadership as Vice President and President, Renesas Electronics India; Industry Veteran Yvonne Liu Appointed Vice President

2026/03/02

Sabre Corporation Adopts Limited-Duration Shareholder Rights Plan

Board acted in response to substantial accumulation of stock by Constellation Software SOUTHLAKE, Texas, March 1, 2026 /PRNewswire/ — Sabre Corporation (“Sabre”

2026/03/02

Yonyou Unveils the Large Ontology Model (LOM): Forging a Deep-Thinking Digital Core for the Enterprise

BEIJING, March 1, 2026 /PRNewswire/ — As enterprise digital transformation advances with increasing depth and precision, the ability to efficiently manage and harness

2026/03/02

Berkshire Hathaway Specialty Insurance Names Marcus Portbury Regional President, Asia Middle East

BOSTON & HONG KONG & SINGAPORE & DUBAI, United Arab Emirates–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced the appointment of Marcus

2026/03/02

GIGABYTE Powers Telecom AI Transformation with End-to-End Infrastructure at MWC 2026

From AI factories and supercomputing to digital twins, cloud hosting, and edge AI, GIGABYTE enables telecommunications operators to turn network data into intelligence

2026/03/02

OLIVE YOUNG Global Kicks Off 2026 Spring Sale Through March 7

Spring Sale Highlights Trending K-Beauty and Wellness Products, Spring Essentials, and Localized Offers for Global Customers SEOUL, South Korea, March 1, 2026 /

2026/03/02

SK Telecom CEO Unveils ‘AI Native’ Strategy at MWC26, Driving Korea’s Leap in AI Innovation

– Seizing the golden time for a major transformation, with ‘Customer Value & AI’ as the top two priorities for driving change – Major overhaul of systems

2026/03/02

XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication

– XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea’s National Health Insurance Service (NHIS) for the treatment of adult patients with

2026/03/02

$Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma$

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

SAN FRANCISCO and SUZHOU, China, March 1, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that

2026/03/02

Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and Commercially Available in Japan

TOKYO–(BUSINESS WIRE)–Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) and Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical) announce that the Paradise

2026/03/02